Official reprint from UpToDate
©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.
Medline ® Abstract for Reference 42
of 'Clinical use of tyrosine kinase inhibitors for chronic myeloid leukemia'
BCR-ABL1 mutation≠ponatinib resistance.
Saglio G, Fava C
Blood. 2016 Feb;127(6):666-7.
UNIVERSITY OF TURIN.